Product Information
DEXLANSOPRAZOLE DR 60 MG CAP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $3.8403 per EA under NDC 62332082430. Its NADAC has been published 18 times since Feb 25, 2026.
Strength
60 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332082430
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DEXLANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA219115On Market Since
11/14/2025
Pharmacological Classes
Price Statistics
The NADAC for DEXLANSOPRAZOLE DR 60 MG CAP has been published 18 times since Feb 25, 2026, and over the history we have for it it has declined 9.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.8403 per EA |
|---|---|
| All-time high | $4.2573 (Mar 11, 2026) |
| All-time low | $3.8403 (Jun 17, 2026) |
| 52-week high | $4.2573 |
| 52-week low | $3.8403 |
| Median price | $4.0638 |
| Average price | $4.0857 |
| Largest weekly change | -3.6% (Apr 22, 2026) |
| Weeks tracked | 18 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEXLANSOPRAZOLE DR 60 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXLANSOPRAZOLE DR 60 MG CAP, manufactured by Alembic Pharmaceuticals Inc., is $3.8403 per EA (NDC 62332082430), effective Jun 24, 2026.
How has the price of DEXLANSOPRAZOLE DR 60 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXLANSOPRAZOLE DR 60 MG CAP has declined 9.8%. It has been tracked across 18 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for DEXLANSOPRAZOLE DR 60 MG CAP?
Since Feb 25, 2026, the NADAC for DEXLANSOPRAZOLE DR 60 MG CAP has ranged from a low of $3.8403 (Jun 17, 2026) to a high of $4.2573 (Mar 11, 2026), with a median of $4.0638 per EA.
Are there cheaper alternatives to DEXLANSOPRAZOLE DR 60 MG CAP?
2 NADAC-published products share the same active ingredient, strength, and dosage form as DEXLANSOPRAZOLE DR 60 MG CAP, but none are currently priced below it.
Who manufactures DEXLANSOPRAZOLE DR 60 MG CAP?
DEXLANSOPRAZOLE DR 60 MG CAP (NDC 62332082430) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification